Materials Healthcare Sector

Helix BioPharma

Market Cap: CA$50.4m

Operates as an immune-oncology company in Canada.

Futura Medical

Market Cap: UK£26.9m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Poolbeg Pharma

Market Cap: UK£26.8m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

Renalytix

Market Cap: UK£26.5m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.

Retrieve Medical Holdings

Market Cap: US$35.5m

Develops software solutions related to data mining, clinical decision support, natural language processing, and algorithmic testing for analyzing patient’s accumulated medical records and lab results in medical center emergency departments.

Rani Therapeutics Holdings

Market Cap: US$35.5m

Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

Lantern Pharma

Market Cap: US$35.5m

Focuses on the discovery and development of oncology drug.

AN2 Therapeutics

Market Cap: US$35.3m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Pluri

Market Cap: US$35.1m

A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries.

Burning Rock Biotech

Market Cap: US$35.0m

Primarily develops and sells cancer therapy selection tests in the People's Republic of China.

Quantum BioPharma

Market Cap: CA$48.2m

Operates as a biopharmaceutical company.

Propanc Biopharma

Market Cap: US$34.8m

A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

Envoy Medical

Market Cap: US$34.8m

A hearing health company, focuses on providing medical technologies across the hearing loss spectrum.

Microbix Biosystems

Market Cap: CA$47.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Rafael Holdings

Market Cap: US$34.6m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.

MedAdvisor

Market Cap: AU$53.7m

Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.

Light AI

Market Cap: CA$47.9m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Proteomics International Laboratories

Market Cap: AU$53.7m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.

Boundless Bio

Market Cap: US$34.5m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

Shield Therapeutics

Market Cap: UK£25.5m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Golden Valley Development

Market Cap: US$34.2m

Through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors.

Reliq Health Technologies

Market Cap: CA$47.3m

A healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.

Defence Therapeutics

Market Cap: CA$47.1m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

Ocumetics Technology

Market Cap: CA$46.7m

Engages in research, development, production, and sale of vision enhancement products in Canada.

LAVA Therapeutics

Market Cap: US$33.7m

Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.

Aligos Therapeutics

Market Cap: US$33.6m

A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.

Rockwell Medical

Market Cap: US$33.5m

Develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.

Compumedics

Market Cap: AU$51.9m

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.

FibroGen

Market Cap: US$33.3m

A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.

Precision Optics Corporation

Market Cap: US$33.2m

Designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

MTL Cannabis

Market Cap: CA$45.6m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

Abingdon Health

Market Cap: UK£24.4m

Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.

KDA Group

Market Cap: CA$45.3m

Provides technological solutions to general and specialized health sectors in Canada.

Tryptamine Therapeutics

Market Cap: AU$50.4m

A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.

Theralase Technologies

Market Cap: CA$44.8m

A clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally.

Cyclacel Pharmaceuticals

Market Cap: US$32.3m

A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.